DAL vs PHAT · P/E 12, rev $61.64B vs rev $55.3M
Delta Air Lines Inc (DAL) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the DAL and PHAT stock pages for the full models.
Not investment advice.